Cognito Therapeutics to Present New Data on Spectris’™ Impact on Brain Structure in Alzheimer’s Disease at AD/PD 2025 ...

Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to ...

Rapport Therapeutics to showcase data at 2025 American Academy of Neurology Annual Meeting in San Diego from April 5-9, 2025: San Diego Tuesday, March 25, 2025, 14:00 Hrs [IST] Ra ...

Rapport Therapeutics (RAPP) announced two encore poster presentations at the 2025 American Academy of Neurology, AAN, Annual Meeting, taking ...

A critical analysis of the latest literature data on changes in the viability of cancer cells under the influence of ...

NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle invasive bladder cancer (NMIBC, U.S. prevalence of ~600,000 ...

Behavioral interventions may reduce migraine frequency and improve migraine-related disability in adult and pediatric patients.

The DR-88 employs radial shockwave therapy, delivering controlled high-frequency, low-energy pulses to the affected area. This technique helps enhance blood circulation, stimulate metabolism, and ...

Preclinical and Phase 1 data suggest that ratutrelvir can be used without ritonavir and may reduce the likelihood of COVID rebound and the risk ...

Purple Day is marked to support those with epilepsy, and create awareness for better access to treatment. Here are the ...

Many seek a deeper connection to their true selves and the universe in a world filled with distractions and overwhelming noise. This quest often leads individuals to explore various spiritual ...

Detailed price information for Trevi Therapeutics Inc (TRVI-Q) from The Globe and Mail including charting and trades.